Alnylam Pharmaceuticals Inc at Nasdaq Investor Conference (Virtual) Transcript
Hi, everyone. My name is Maury Raycroft. And I'm one of the biotech analysts at Jefferies. So it's great pleasure that I'd like to welcome Jeff Poulton, the CFO of Alnylam. Thanks for joining us today, Jeff.
Thanks, Maurice. It's great to be here with you today.
And Alnylam is a very interesting company with RNAi therapeutics, cutting-edge technology I would say. Jeff, maybe to start off, if you want to provide a 1-minute intro to Alnylam.
Great. I'll try and keep it to a minute. You're right. There's a lot of exciting things going on at Alnylam. We're the leader in RNAi therapeutics, pioneering a whole new class of medicines. And the profile of the company today is a fully
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
